A General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.
A new technical report guides bio/pharma companies in establishing a risk-based approach for prevention and management of drug shortages.
The all-synthetic clarifying product line contains both an anion-exchange nonwoven media and a fine-particle, bioburden reduction membrane.
Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.
As an affiliate member, TraceLink brings serialization expertise to the Pharma & Biopharma Outsourcing Association.
Is there enough talent to go around?
Drug makers back alternative to FDA labeling update rule.
FDA has approved another indication for Eylea, a treatment for diabetic retinopathy in patients with diabetic macular edema.
The agency provides guidance on determining the need for environmental assessments for gene therapies, vectored vaccines, and viral and microbial products.